|
|
|||
|
||||
OverviewSupplementary Protection Certificates (SPCs) (patents extensions) for pharmaceutical and veterinary products were introduced in Europe in 1993. In 1996, a similar regime was introduced for agrochemical (crop protection) products. SPCs extend the period of protection given by a patent for a maximum of five years after the patent has expired. They were intended to compensate patent holders for the loss of exclusivity caused by the requirement in the pharmaceutical and agrochemical industries to obtain regulatory approval before a product can be marketed. SPCs are of enormous commercial significance to the pharmaceutical and biotechnology industries, since they provide additional monopoly protection at a time when many products are reaching peak sales. This book provides a practical, unifying and comprehensive guide to the law as it now stands. Full Product DetailsAuthor: D Curley , Duncan CurleyPublisher: Woodhead Publishing Imprint: Woodhead Publishing ISBN: 9780857091697ISBN 10: 0857091697 Pages: 200 Publication Date: 28 November 2014 Audience: General/trade , General Format: Paperback Publisher's Status: No Longer Our Product Availability: Awaiting stock The supplier is currently out of stock of this item. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out for you. Table of ContentsReviewsAuthor InformationDr. Duncan Curley trained and qualified in the intellectual property department of a 'magic circle' law firm in London, eventually becoming a partner at the international law firm of McDermott, Will & Emery. He set up his own law firm - Innovate Legal - in June 2007, specialising in advice to companies operating in the pharmaceutical and biotech sectors. Dr Curley has appeared in a number of high profile cases throughout his career, including Lenzing v Courtaulds (judicial review of a decision by the European Patent Office), Bespak v 3M (patent revocation proceedings concerning metered dose inhalers) and BioProgress v Stanelco (patent dispute concerning drug encapsulation technology). Tab Content 6Author Website:Countries AvailableAll regions |